aluates Reports

$ 0.0

Automative

Global Amebiasis Therapeutics Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-23A13804

Global Amebiasis Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Amebiasis Therapeutics Market Insights, Forecast to 2030

Code: QYRE-Auto-23A13804

Report

December 2024

Pages:111

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Dr. Reddy’s Laboratories

Mission Pharmacal

Aceto Corporation

Mylan Pharmaceuticals

Impax Laboratories

Pfizer Inc

Sanofi

Lupin Pharmaceuticals

Glenmark Pharmaceuticals

Sun Pharmaceutical

Heritage Pharmaceuticals

Amebiasis Therapeutics Market Size

The global Amebiasis Therapeutics market is projected to grow from US$ 928 million in 2024 to US$ 1323.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period.

Amebiasis Therapeutics Market

Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain.

Market Analysis and Insights: Global Amebiasis Therapeutics Market

The amebiasis drugs market is driven by the high burden of amebiasis infections, caused by the parasite Entamoeba histolytica, especially in developing regions with poor sanitation and healthcare facilities. Amebiasis can lead to severe gastrointestinal symptoms and potentially life-threatening complications. The increasing prevalence and severity of the disease have contributed to the demand for effective drugs to treat and manage amebiasis. Additionally, advancements in medical research and drug development have led to the introduction of new and improved therapies for better patient outcomes. However, challenges include the need for early diagnosis and proper management to prevent complications, potential drug resistance, and limited access to healthcare in some regions. Overcoming these challenges through increased awareness, affordable treatment options, and improved healthcare infrastructure will be crucial for the sustained growth of the amebiasis drugs market.

Report Covers:

This report presents an overview of global market for Amebiasis Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Amebiasis Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Amebiasis Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Amebiasis Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Amebiasis Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Amebiasis Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Amebiasis Therapeutics Market Report

Report Metric	Details
Report Name	Amebiasis Therapeutics Market
Accounted market size in 2024	US$ 928 million
Forecasted market size in 2030	US$ 1323.9 million
CAGR	6.1
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Metronidazole Paromomycin Tinidazole Other
Segment by Application	Hospital Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Dr. Reddy’s Laboratories, Mission Pharmacal, Aceto Corporation, Mylan Pharmaceuticals, Impax Laboratories, Pfizer, Sanofi, Lupin Pharmaceuticals, Glenmark Pharmaceuticals, Sun Pharmaceutical, Heritage Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Amebiasis Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amebiasis Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Amebiasis Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Amebiasis Therapeutics Market growing?

Ans: The Amebiasis Therapeutics Market witnessing a CAGR of 6.1 during the forecast period 2025-2030.

What is the Amebiasis Therapeutics Market size in 2030?

Ans: The Amebiasis Therapeutics Market size in 2030 will be US$ 1323.9 million.

Who are the main players in the Amebiasis Therapeutics Market report?

Ans: The main players in the Amebiasis Therapeutics Market are Dr. Reddy’s Laboratories, Mission Pharmacal, Aceto Corporation, Mylan Pharmaceuticals, Impax Laboratories, Pfizer, Sanofi, Lupin Pharmaceuticals, Glenmark Pharmaceuticals, Sun Pharmaceutical, Heritage Pharmaceuticals

What are the Application segmentation covered in the Amebiasis Therapeutics Market report?

Ans: The Applications covered in the Amebiasis Therapeutics Market report are Hospital, Pharmacy

What are the Type segmentation covered in the Amebiasis Therapeutics Market report?

Ans: The Types covered in the Amebiasis Therapeutics Market report are Metronidazole, Paromomycin, Tinidazole, Other

Recommended Reports

Intestinal & GI Diseases

Parasitic & Infectious

Anti-Infective Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Amebiasis Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Metronidazole

1.2.3 Paromomycin

1.2.4 Tinidazole

1.2.5 Other

1.3 Market by Application

1.3.1 Global Amebiasis Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Amebiasis Therapeutics Market Perspective (2019-2030)

2.2 Global Amebiasis Therapeutics Growth Trends by Region

2.2.1 Amebiasis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Amebiasis Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Amebiasis Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Amebiasis Therapeutics Market Dynamics

2.3.1 Amebiasis Therapeutics Industry Trends

2.3.2 Amebiasis Therapeutics Market Drivers

2.3.3 Amebiasis Therapeutics Market Challenges

2.3.4 Amebiasis Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Amebiasis Therapeutics by Players

3.1.1 Global Amebiasis Therapeutics Revenue by Players (2019-2024)

3.1.2 Global Amebiasis Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Amebiasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Amebiasis Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Amebiasis Therapeutics Market Concentration Ratio

3.4.1 Global Amebiasis Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Amebiasis Therapeutics Revenue in 2023

3.5 Global Key Players of Amebiasis Therapeutics Head office and Area Served

3.6 Global Key Players of Amebiasis Therapeutics, Product and Application

3.7 Global Key Players of Amebiasis Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Amebiasis Therapeutics Breakdown Data by Type

4.1 Global Amebiasis Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Amebiasis Therapeutics Forecasted Market Size by Type (2025-2030)

5 Amebiasis Therapeutics Breakdown Data by Application

5.1 Global Amebiasis Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Amebiasis Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Amebiasis Therapeutics Market Size (2019-2030)

6.2 North America Amebiasis Therapeutics Market Size by Type

6.2.1 North America Amebiasis Therapeutics Market Size by Type (2019-2024)

6.2.2 North America Amebiasis Therapeutics Market Size by Type (2025-2030)

6.2.3 North America Amebiasis Therapeutics Market Share by Type (2019-2030)

6.3 North America Amebiasis Therapeutics Market Size by Application

6.3.1 North America Amebiasis Therapeutics Market Size by Application (2019-2024)

6.3.2 North America Amebiasis Therapeutics Market Size by Application (2025-2030)

6.3.3 North America Amebiasis Therapeutics Market Share by Application (2019-2030)

6.4 North America Amebiasis Therapeutics Market Size by Country

6.4.1 North America Amebiasis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Amebiasis Therapeutics Market Size by Country (2019-2024)

6.4.3 North America Amebiasis Therapeutics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Amebiasis Therapeutics Market Size (2019-2030)

7.2 Europe Amebiasis Therapeutics Market Size by Type

7.2.1 Europe Amebiasis Therapeutics Market Size by Type (2019-2024)

7.2.2 Europe Amebiasis Therapeutics Market Size by Type (2025-2030)

7.2.3 Europe Amebiasis Therapeutics Market Share by Type (2019-2030)

7.3 Europe Amebiasis Therapeutics Market Size by Application

7.3.1 Europe Amebiasis Therapeutics Market Size by Application (2019-2024)

7.3.2 Europe Amebiasis Therapeutics Market Size by Application (2025-2030)

7.3.3 Europe Amebiasis Therapeutics Market Share by Application (2019-2030)

7.4 Europe Amebiasis Therapeutics Market Size by Country

7.4.1 Europe Amebiasis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Amebiasis Therapeutics Market Size by Country (2019-2024)

7.4.3 Europe Amebiasis Therapeutics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Amebiasis Therapeutics Market Size (2019-2030)

8.2 China Amebiasis Therapeutics Market Size by Type

8.2.1 China Amebiasis Therapeutics Market Size by Type (2019-2024)

8.2.2 China Amebiasis Therapeutics Market Size by Type (2025-2030)

8.2.3 China Amebiasis Therapeutics Market Share by Type (2019-2030)

8.3 China Amebiasis Therapeutics Market Size by Application

8.3.1 China Amebiasis Therapeutics Market Size by Application (2019-2024)

8.3.2 China Amebiasis Therapeutics Market Size by Application (2025-2030)

8.3.3 China Amebiasis Therapeutics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Amebiasis Therapeutics Market Size (2019-2030)

9.2 Asia Amebiasis Therapeutics Market Size by Type

9.2.1 Asia Amebiasis Therapeutics Market Size by Type (2019-2024)

9.2.2 Asia Amebiasis Therapeutics Market Size by Type (2025-2030)

9.2.3 Asia Amebiasis Therapeutics Market Share by Type (2019-2030)

9.3 Asia Amebiasis Therapeutics Market Size by Application

9.3.1 Asia Amebiasis Therapeutics Market Size by Application (2019-2024)

9.3.2 Asia Amebiasis Therapeutics Market Size by Application (2025-2030)

9.3.3 Asia Amebiasis Therapeutics Market Share by Application (2019-2030)

9.4 Asia Amebiasis Therapeutics Market Size by Region

9.4.1 Asia Amebiasis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Amebiasis Therapeutics Market Size by Region (2019-2024)

9.4.3 Asia Amebiasis Therapeutics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Amebiasis Therapeutics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Amebiasis Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Amebiasis Therapeutics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Amebiasis Therapeutics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Amebiasis Therapeutics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Amebiasis Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Amebiasis Therapeutics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Amebiasis Therapeutics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Amebiasis Therapeutics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Amebiasis Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Amebiasis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Amebiasis Therapeutics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Amebiasis Therapeutics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Dr. Reddy’s Laboratories

11.1.1 Dr. Reddy’s Laboratories Company Details

11.1.2 Dr. Reddy’s Laboratories Business Overview

11.1.3 Dr. Reddy’s Laboratories Amebiasis Therapeutics Introduction

11.1.4 Dr. Reddy’s Laboratories Revenue in Amebiasis Therapeutics Business (2019-2024)

11.1.5 Dr. Reddy’s Laboratories Recent Developments

11.2 Mission Pharmacal

11.2.1 Mission Pharmacal Company Details

11.2.2 Mission Pharmacal Business Overview

11.2.3 Mission Pharmacal Amebiasis Therapeutics Introduction

11.2.4 Mission Pharmacal Revenue in Amebiasis Therapeutics Business (2019-2024)

11.2.5 Mission Pharmacal Recent Developments

11.3 Aceto Corporation

11.3.1 Aceto Corporation Company Details

11.3.2 Aceto Corporation Business Overview

11.3.3 Aceto Corporation Amebiasis Therapeutics Introduction

11.3.4 Aceto Corporation Revenue in Amebiasis Therapeutics Business (2019-2024)

11.3.5 Aceto Corporation Recent Developments

11.4 Mylan Pharmaceuticals

11.4.1 Mylan Pharmaceuticals Company Details

11.4.2 Mylan Pharmaceuticals Business Overview

11.4.3 Mylan Pharmaceuticals Amebiasis Therapeutics Introduction

11.4.4 Mylan Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2019-2024)

11.4.5 Mylan Pharmaceuticals Recent Developments

11.5 Impax Laboratories

11.5.1 Impax Laboratories Company Details

11.5.2 Impax Laboratories Business Overview

11.5.3 Impax Laboratories Amebiasis Therapeutics Introduction

11.5.4 Impax Laboratories Revenue in Amebiasis Therapeutics Business (2019-2024)

11.5.5 Impax Laboratories Recent Developments

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Amebiasis Therapeutics Introduction

11.6.4 Pfizer Revenue in Amebiasis Therapeutics Business (2019-2024)

11.6.5 Pfizer Recent Developments

11.7 Sanofi

11.7.1 Sanofi Company Details

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Amebiasis Therapeutics Introduction

11.7.4 Sanofi Revenue in Amebiasis Therapeutics Business (2019-2024)

11.7.5 Sanofi Recent Developments

11.8 Lupin Pharmaceuticals

11.8.1 Lupin Pharmaceuticals Company Details

11.8.2 Lupin Pharmaceuticals Business Overview

11.8.3 Lupin Pharmaceuticals Amebiasis Therapeutics Introduction

11.8.4 Lupin Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2019-2024)

11.8.5 Lupin Pharmaceuticals Recent Developments

11.9 Glenmark Pharmaceuticals

11.9.1 Glenmark Pharmaceuticals Company Details

11.9.2 Glenmark Pharmaceuticals Business Overview

11.9.3 Glenmark Pharmaceuticals Amebiasis Therapeutics Introduction

11.9.4 Glenmark Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2019-2024)

11.9.5 Glenmark Pharmaceuticals Recent Developments

11.10 Sun Pharmaceutical

11.10.1 Sun Pharmaceutical Company Details

11.10.2 Sun Pharmaceutical Business Overview

11.10.3 Sun Pharmaceutical Amebiasis Therapeutics Introduction

11.10.4 Sun Pharmaceutical Revenue in Amebiasis Therapeutics Business (2019-2024)

11.10.5 Sun Pharmaceutical Recent Developments

11.11 Heritage Pharmaceuticals

11.11.1 Heritage Pharmaceuticals Company Details

11.11.2 Heritage Pharmaceuticals Business Overview

11.11.3 Heritage Pharmaceuticals Amebiasis Therapeutics Introduction

11.11.4 Heritage Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2019-2024)

11.11.5 Heritage Pharmaceuticals Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Dr. Reddy’s Laboratories

Mission Pharmacal

Aceto Corporation

Mylan Pharmaceuticals

Impax Laboratories

Pfizer Inc

Sanofi

Lupin Pharmaceuticals

Glenmark Pharmaceuticals

Sun Pharmaceutical

Heritage Pharmaceuticals

List of Tables

Table 1. Global Amebiasis Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Metronidazole

Table 3. Key Players of Paromomycin

Table 4. Key Players of Tinidazole

Table 5. Key Players of Other

Table 6. Global Amebiasis Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Amebiasis Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Amebiasis Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Amebiasis Therapeutics Market Share by Region (2019-2024)

Table 10. Global Amebiasis Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Amebiasis Therapeutics Market Share by Region (2025-2030)

Table 12. Amebiasis Therapeutics Market Trends

Table 13. Amebiasis Therapeutics Market Drivers

Table 14. Amebiasis Therapeutics Market Challenges

Table 15. Amebiasis Therapeutics Market Restraints

Table 16. Global Amebiasis Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Amebiasis Therapeutics Revenue Share by Players (2019-2024)

Table 18. Global Top Amebiasis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amebiasis Therapeutics as of 2023)

Table 19. Global Amebiasis Therapeutics Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Amebiasis Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Amebiasis Therapeutics, Headquarters and Area Served

Table 22. Global Key Players of Amebiasis Therapeutics, Product and Application

Table 23. Global Key Players of Amebiasis Therapeutics, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Amebiasis Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Amebiasis Therapeutics Revenue Market Share by Type (2019-2024)

Table 27. Global Amebiasis Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Amebiasis Therapeutics Revenue Market Share by Type (2025-2030)

Table 29. Global Amebiasis Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Amebiasis Therapeutics Revenue Share by Application (2019-2024)

Table 31. Global Amebiasis Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Amebiasis Therapeutics Revenue Share by Application (2025-2030)

Table 33. North America Amebiasis Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Amebiasis Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Amebiasis Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Amebiasis Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Amebiasis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Amebiasis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Amebiasis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Amebiasis Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Amebiasis Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Amebiasis Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Amebiasis Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Amebiasis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Amebiasis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Amebiasis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Amebiasis Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Amebiasis Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Amebiasis Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Amebiasis Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Amebiasis Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Amebiasis Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Amebiasis Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Amebiasis Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Amebiasis Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Amebiasis Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Amebiasis Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Amebiasis Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Amebiasis Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Amebiasis Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Amebiasis Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Amebiasis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Amebiasis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Amebiasis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 65. Dr. Reddy’s Laboratories Company Details

Table 66. Dr. Reddy’s Laboratories Business Overview

Table 67. Dr. Reddy’s Laboratories Amebiasis Therapeutics Product

Table 68. Dr. Reddy’s Laboratories Revenue in Amebiasis Therapeutics Business (2019-2024) & (US$ Million)

Table 69. Dr. Reddy’s Laboratories Recent Developments

Table 70. Mission Pharmacal Company Details

Table 71. Mission Pharmacal Business Overview

Table 72. Mission Pharmacal Amebiasis Therapeutics Product

Table 73. Mission Pharmacal Revenue in Amebiasis Therapeutics Business (2019-2024) & (US$ Million)

Table 74. Mission Pharmacal Recent Developments

Table 75. Aceto Corporation Company Details

Table 76. Aceto Corporation Business Overview

Table 77. Aceto Corporation Amebiasis Therapeutics Product

Table 78. Aceto Corporation Revenue in Amebiasis Therapeutics Business (2019-2024) & (US$ Million)

Table 79. Aceto Corporation Recent Developments

Table 80. Mylan Pharmaceuticals Company Details

Table 81. Mylan Pharmaceuticals Business Overview

Table 82. Mylan Pharmaceuticals Amebiasis Therapeutics Product

Table 83. Mylan Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2019-2024) & (US$ Million)

Table 84. Mylan Pharmaceuticals Recent Developments

Table 85. Impax Laboratories Company Details

Table 86. Impax Laboratories Business Overview

Table 87. Impax Laboratories Amebiasis Therapeutics Product

Table 88. Impax Laboratories Revenue in Amebiasis Therapeutics Business (2019-2024) & (US$ Million)

Table 89. Impax Laboratories Recent Developments

Table 90. Pfizer Company Details

Table 91. Pfizer Business Overview

Table 92. Pfizer Amebiasis Therapeutics Product

Table 93. Pfizer Revenue in Amebiasis Therapeutics Business (2019-2024) & (US$ Million)

Table 94. Pfizer Recent Developments

Table 95. Sanofi Company Details

Table 96. Sanofi Business Overview

Table 97. Sanofi Amebiasis Therapeutics Product

Table 98. Sanofi Revenue in Amebiasis Therapeutics Business (2019-2024) & (US$ Million)

Table 99. Sanofi Recent Developments

Table 100. Lupin Pharmaceuticals Company Details

Table 101. Lupin Pharmaceuticals Business Overview

Table 102. Lupin Pharmaceuticals Amebiasis Therapeutics Product

Table 103. Lupin Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2019-2024) & (US$ Million)

Table 104. Lupin Pharmaceuticals Recent Developments

Table 105. Glenmark Pharmaceuticals Company Details

Table 106. Glenmark Pharmaceuticals Business Overview

Table 107. Glenmark Pharmaceuticals Amebiasis Therapeutics Product

Table 108. Glenmark Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2019-2024) & (US$ Million)

Table 109. Glenmark Pharmaceuticals Recent Developments

Table 110. Sun Pharmaceutical Company Details

Table 111. Sun Pharmaceutical Business Overview

Table 112. Sun Pharmaceutical Amebiasis Therapeutics Product

Table 113. Sun Pharmaceutical Revenue in Amebiasis Therapeutics Business (2019-2024) & (US$ Million)

Table 114. Sun Pharmaceutical Recent Developments

Table 115. Heritage Pharmaceuticals Company Details

Table 116. Heritage Pharmaceuticals Business Overview

Table 117. Heritage Pharmaceuticals Amebiasis Therapeutics Product

Table 118. Heritage Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2019-2024) & (US$ Million)

Table 119. Heritage Pharmaceuticals Recent Developments

Table 120. Research Programs/Design for This Report

Table 121. Key Data Information from Secondary Sources

Table 122. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Amebiasis Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Amebiasis Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Metronidazole Features

Figure 4. Paromomycin Features

Figure 5. Tinidazole Features

Figure 6. Other Features

Figure 7. Global Amebiasis Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Amebiasis Therapeutics Market Share by Application: 2023 VS 2030

Figure 9. Hospital Case Studies

Figure 10. Pharmacy Case Studies

Figure 11. Amebiasis Therapeutics Report Years Considered

Figure 12. Global Amebiasis Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Amebiasis Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Amebiasis Therapeutics Market Share by Region: 2023 VS 2030

Figure 15. Global Amebiasis Therapeutics Market Share by Players in 2023

Figure 16. Global Top Amebiasis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amebiasis Therapeutics as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Amebiasis Therapeutics Revenue in 2023

Figure 18. North America Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Amebiasis Therapeutics Market Share by Type (2019-2030)

Figure 20. North America Amebiasis Therapeutics Market Share by Application (2019-2030)

Figure 21. North America Amebiasis Therapeutics Market Share by Country (2019-2030)

Figure 22. United States Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Amebiasis Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Amebiasis Therapeutics Market Share by Type (2019-2030)

Figure 26. Europe Amebiasis Therapeutics Market Share by Application (2019-2030)

Figure 27. Europe Amebiasis Therapeutics Market Share by Country (2019-2030)

Figure 28. Germany Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Amebiasis Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Amebiasis Therapeutics Market Share by Type (2019-2030)

Figure 36. China Amebiasis Therapeutics Market Share by Application (2019-2030)

Figure 37. Asia Amebiasis Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Amebiasis Therapeutics Market Share by Type (2019-2030)

Figure 39. Asia Amebiasis Therapeutics Market Share by Application (2019-2030)

Figure 40. Asia Amebiasis Therapeutics Market Share by Region (2019-2030)

Figure 41. Japan Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Amebiasis Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Amebiasis Therapeutics Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Amebiasis Therapeutics Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Amebiasis Therapeutics Market Share by Country (2019-2030)

Figure 51. Brazil Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Amebiasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Dr. Reddy’s Laboratories Revenue Growth Rate in Amebiasis Therapeutics Business (2019-2024)

Figure 58. Mission Pharmacal Revenue Growth Rate in Amebiasis Therapeutics Business (2019-2024)

Figure 59. Aceto Corporation Revenue Growth Rate in Amebiasis Therapeutics Business (2019-2024)

Figure 60. Mylan Pharmaceuticals Revenue Growth Rate in Amebiasis Therapeutics Business (2019-2024)

Figure 61. Impax Laboratories Revenue Growth Rate in Amebiasis Therapeutics Business (2019-2024)

Figure 62. Pfizer Revenue Growth Rate in Amebiasis Therapeutics Business (2019-2024)

Figure 63. Sanofi Revenue Growth Rate in Amebiasis Therapeutics Business (2019-2024)

Figure 64. Lupin Pharmaceuticals Revenue Growth Rate in Amebiasis Therapeutics Business (2019-2024)

Figure 65. Glenmark Pharmaceuticals Revenue Growth Rate in Amebiasis Therapeutics Business (2019-2024)

Figure 66. Sun Pharmaceutical Revenue Growth Rate in Amebiasis Therapeutics Business (2019-2024)

Figure 67. Heritage Pharmaceuticals Revenue Growth Rate in Amebiasis Therapeutics Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Amebiasis Market Insights Forecast to 2030

Global Amebiasis Drugs Market Insights Forecast to 2030

Global Parasitic Diseases Therapeutic Market Insights Forecast to 2030

Intestinal Ascariasis Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Leishmaniasis Treatment Market Insights Forecast to 2030

Global Ectoparasiticides Market Insights Forecast to 2030

Global Digestive Drugs Market Insights Forecast to 2030

Enteric Parasite Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anemia Treatment Drugs Market Insights Forecast to 2030

Global Animal Therapeutics and Diagnostics Market Insights Forecast to 2030

Global Alzheimer s Disease Therapeutics and Diagnostics Market Insights Forecast to 2030

Global Gastrointestinal Therapeutics Market Research Report 2024

Gastrointestinal Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Metabolic Disorder Therapeutics Market Insights Forecast to 2030

Global Sexually Transmitted Disease Therapeutics Market Insights Forecast to 2030

Global Cryptococcosis Treatment Market Insights Forecast to 2030

Global Infectious Disease Drugs Market Insights Forecast to 2030

Global Poliomyelitis Therapeutics Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions